Kolexia
El Kouri Claude Oncologie médicale
El Kouri Claude
Oncologie médicale
Alek Onco
Nantes, France
65 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs de la prostate Tumeurs du sein Adénocarcinome Tumeurs du poumon Carcinomes Carcinome pulmonaire non à petites cellules Néphrocarcinome Tumeurs de l'ovaire Métastase tumorale

Collaborateurs

Voir plus
Supiot Stephane
Supiot Stephane
Institut de cancérologie de l'Ouest, Saint-Herblain, France
Abadie-Lacourtoisie Sophie
Abadie-Lacourtoisie Sophie
Ico - Site Paul Papin, Angers, France
Laguerre Brigitte
Laguerre Brigitte
Centre Eugène Marquis, Rennes, France
Rigaud Jerome
Rigaud Jerome
Hôpital Hôtel-Dieu Nantes, Nantes, France

Industries

Voir plus
A+A
46 collaboration(s)
Dernière en 2023
Janssen
19 collaboration(s)
Dernière en 2023
Ipsen
11 collaboration(s)
Dernière en 2023
Astellas
10 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
PEACE1: A Prospective Randomised Phase III Study Of Androgen Deprivation Therapy With Or Without Docetaxel With Or Without Local Radiotherapy With Or Without Abiraterone Acetate And Prednisone In Patients With Metastatic Hormone-Naïve Prostate Cancer
Essai Clinique (Ipsen)   07 novembre 2023
MYCA: Phase Ib / II Trial Evaluating the Association Myocet ® - Carboplatine in Patients Having a Cancer of the Ovary in Relapse, Sensitive to the Platinum
Essai Clinique (ARCAGY/ GINECO GROUP)   05 septembre 2023
DURVALUNG: A Phase II Study of Durvalumab (MEDI 4736) Maintenance in Frail Limited Disease Small Cell Lung Cancer Patients After Thoracic Chemoradiotherapy (CRT)
Essai Clinique (AstraZeneca)   27 mars 2023
PEACE2: A Randomized Phase III, Factorial Design, of Cabazitaxel and Pelvic Radiotherapy in Patients With Localized Prostate Cancer and High-risk Features of Relapse
Essai Clinique (Sanofi)   28 octobre 2022
465P Larotracking: Real-life study of locally advanced/metastatic solid tumor treated with larotrectinib in French expanded access program
Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022   01 septembre 2022
Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design.
Lancet (London, England)   08 avril 2022
TAXOMET: A French Prospective Multicentric Randomized Phase II Study of Docetaxel Plus Metformin Versus Docetaxel Plus Placebo in Metastatic Castration-Resistant Prostate Cancer.
Clinical genitourinary cancer   17 septembre 2021
Hormone Therapy and Docetaxel or Hormone Therapy Alone in Treating Patients With Metastatic Prostate Cancer: Randomized Phase III Trial Comparing an Association of Hormonal Treatment and Docetaxel Versus the Hormonal Treatment Alone in Metastatic Prostate Cancers
Essai Clinique (Unicancer)   19 février 2021
Long survival of patients with metastatic clear cell renal cell carcinoma. Results of real life study of 344 patients.
International journal of cancer   01 août 2019
KALICOU3: Evaluation of the Impact of Emotional Skills of Young Women (≤ 45 Years), With Non-metastatic Breast Cancer, and Their Partner on Adjustment to Cancer
Essai Clinique (Centre Oscar-Lambret)   24 juin 2019